For: | Zhang X, Jin WW, Wang HG. Correlation between the neuroendocrine axis, microbial species, inflammatory response, and gastrointestinal symptoms in irritable bowel syndrome. World J Gastroenterol 2024; 30(35): 3985-3995 [PMID: 39351052 DOI: 10.3748/wjg.v30.i35.3985] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i35/3985.htm |
Number | Citing Articles |
1 |
Lemonica Koumbi, Maria-Anna Giannelou, Lorys Castelli. The gut–brain axis in irritable bowel syndrome: neuroendocrine and epigenetic pathways. Academia Biology 2025; 3(2) doi: 10.20935/AcadBiol7748
|
2 |
Raffaele Pellegrino, Antonietta Gerarda Gravina. Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage. World Journal of Gastroenterology 2025; 31(8): 101357 doi: 10.3748/wjg.v31.i8.101357
|
3 |
Martin D. Lehner, Philippe Ulsemer, Sandra Christochowitz. Menthacarin, a proprietary combination of peppermint and caraway oil, alters cultured human fecal microbiota composition, resulting in increased SCFA production. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1569052
|
4 |
Yu Yan, Liang Liu, Xing‐Jie Shen. Comment on “Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome”. Journal of Gastroenterology and Hepatology 2025; doi: 10.1111/jgh.70032
|
5 |
Duygu Kirkik, Sevgi Kalkanli Tas. Unveiling the intricacies of irritable bowel syndrome. World Journal of Gastroenterology 2024; 30(44): 4763-4767 doi: 10.3748/wjg.v30.i44.4763
|